Published on
May 1, 2025
Dr Randall on the Use of Osteosarcoma Spheroid Models to Streamline Preclinical Therapeutic Development
[Spheroids] are easy to produce [and] potentially introduce agents that we are considering for clinical development. If we get an effect, we can take it to the engineered bone marrow model, then into a clinical trial.” R. Lor Randall, MD, FASCO, chair of …
Source:
OncLive
-
Pending
